Logo (EUIPO, 07/24/2023)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark was filed as Figurative mark on 07/24/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/19/2023.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Circles or ellipses with lines (except 26.7.3.)
| Trademark form | Figurative mark |
| File reference | 018905134 |
| Application date | July 24, 2023 |
| Publication date | September 11, 2023 |
| Entry date | December 19, 2023 |
| Expiration date | July 24, 2033 |
Trademark owner
Suite 270, 9605 Medical Center Dr.
20850 Rockville
US
20850 Rockville
US
Trademark representatives
7 Rue Guimard
1040 Brussels
BE
goods and services
5
Pharmaceutical preparations for the treatment, prevention and alleviation of gastrointestinal diseases, infections, dysbiosis, and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal health, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for gastrointestinal dysbiosis, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for systemic illnesses associated with gastrointestinal dysbiosis, gastrointestinal disorders, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for systemic illnesses associated with gastrointestinal disorders, gastrointestinal diseases, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for systemic illnesses associated with gastrointestinal diseases, gastrointestinal infections, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceuticals, namely, pharmaceutical preparations for systemic illnesses associated with gastrointestinal infections, used to maintain health and restore health to a human or animal subject via treatment of a disturbed microbial community and prevention of microbial community disruption; Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; oncolytic viral therapies; biological therapies for use in the treatment of cancer and tumors
ID: 11018905134